In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease ...
November 12, 2009 - Positron Corp. predicts an industry wide demand for cardiac PET imaging, as a result of the ...
November 6, 2009 - As the American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for ...
November 4, 2009 - The Centers for Medicare and Medicaid Services (CMS) released the review copy of the 2010 ...
November 3, 2009 – By relying solely on a patient’s clinical risk profile or the results of one imaging test when ...
October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized ...
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete ...
October 11, 2009 – GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform ...
October 6, 2009 – Siemens Healthcare announced the availability of syngo Dynamic PET with myocardial blood flow, a ...
September 30, 2009 – Positron Corp. predicts a significant rise in demand for cardiac PET in 2010 with a proposed ...
September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will ...
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd ...

Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but ...
September 17, 2009 - Inflation rates for healthcare supplies are projected to remain unchanged through 2010 ...